ALVR - AlloVir spikes as Bank of America starts at Buy on lead asset
2023-08-18 10:05:13 ET
More on AlloVir
- AlloVir: 'Takes One To Know One'
- AlloVir: Several Late-Stage Programs Make This Worth A Look
- AlloVir spikes as Gilead buys over $10M stock
- AlloVir gains after long-term mortality data for lead asset
- AlloVir falls 15% as Executive Chairman reports over $5M share sale
For further details see:
AlloVir spikes as Bank of America starts at Buy on lead asset